EarlySight SA

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument empowering doctors to see the first disease impacts. About 25% of people over 60 years old in industrialized countries are affected by eye diseases. Most of these diseases (e.g., AMD, glaucoma) are starting with the degeneration of the eye retina cellular structure which is invisible to current examinations. Consequently, the diagnosis and treatment of retinal diseases is made too late. Our proprietary eye imaging technology allows the observation of the tissue degenerative process associated with eye diseases, and detects its evolution, enabling early diagnosis, precise monitoring, and better treatments.